126 related articles for article (PubMed ID: 16394626)
21. Radiosensitization by intratumoral administration of cisplatin in a sustained-release drug delivery system.
Ning S; Yu N; Brown DM; Kanekal S; Knox SJ
Radiother Oncol; 1999 Feb; 50(2):215-23. PubMed ID: 10368046
[TBL] [Abstract][Full Text] [Related]
22. Radiosensitizing effect of nicotinamide and carbogen combined in fractionated pions or x-rays in SCCVII tumors.
Ohizumi Y; Lam GK; Pickles T; Fryer C; Chaplin DJ
Radiat Med; 1995; 13(6):291-5. PubMed ID: 8850370
[TBL] [Abstract][Full Text] [Related]
23. DNA damage in cultured skin microvascular endothelial cells exposed to gamma rays and treated by the combination pentoxifylline and alpha-tocopherol.
Laurent C; Voisin P; Pouget JP
Int J Radiat Biol; 2006 May; 82(5):309-21. PubMed ID: 16782648
[TBL] [Abstract][Full Text] [Related]
24. Reduction of tumor hypoxia and inhibition of DNA repair by nicotinamide after irradiation of SCCVII murine tumors and normal tissues.
Zheng H; Olive PL
Cancer Res; 1996 Jun; 56(12):2801-8. PubMed ID: 8665517
[TBL] [Abstract][Full Text] [Related]
25. RSR13, an allosteric effector of haemoglobin, and carbogen radiosensitize FSAII and SCCVII tumours in C3H mice.
Khandelwal SR; Kavanagh BD; Lin PS; Truong QT; Lu J; Abraham DJ; Schmidt-Ullrich RK
Br J Cancer; 1999 Feb; 79(5-6):814-20. PubMed ID: 10070874
[TBL] [Abstract][Full Text] [Related]
26. Changes in tumour blood flow, oxygenation and interstitial fluid pressure induced by pentoxifylline.
Lee I; Boucher Y; Demhartner TJ; Jain RK
Br J Cancer; 1994 Mar; 69(3):492-6. PubMed ID: 8123479
[TBL] [Abstract][Full Text] [Related]
27. Reevaluation of the radiosensitizing effects of sanazole and nimorazole in vitro and in vivo.
Sugie C; Shibamoto Y; Ito M; Ogino H; Suzuki H; Uto Y; Nagasawa H; Hori H
J Radiat Res; 2005 Dec; 46(4):453-9. PubMed ID: 16394636
[TBL] [Abstract][Full Text] [Related]
28. The effects of nicotinamide plus carbogen or pions for microscopic SCCVII tumors.
Nishioka A; Ohizumi Y; Lam GK; Pickles TA; Chaplin DJ; Ogawa Y; Inomata T; Yoshida S
Oncol Rep; 1999; 6(3):583-6. PubMed ID: 10203595
[TBL] [Abstract][Full Text] [Related]
29. Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel.
Milas L; Hunter NR; Mason KA; Milross CG; Saito Y; Peters LJ
Cancer Res; 1995 Aug; 55(16):3564-8. PubMed ID: 7627965
[TBL] [Abstract][Full Text] [Related]
30. A Multimodal Molecular Imaging Study Evaluates Pharmacological Alteration of the Tumor Microenvironment to Improve Radiation Response.
Takakusagi Y; Naz S; Takakusagi K; Ishima M; Murata H; Ohta K; Miura M; Sugawara F; Sakaguchi K; Kishimoto S; Munasinghe JP; Mitchell JB; Krishna MC
Cancer Res; 2018 Dec; 78(24):6828-6837. PubMed ID: 30301838
[TBL] [Abstract][Full Text] [Related]
31. Effect of intratumoral heterogeneity in oxygenation status on FMISO PET, autoradiography, and electrode Po2 measurements in murine tumors.
Sørensen M; Horsman MR; Cumming P; Munk OL; Keiding S
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):854-61. PubMed ID: 15936570
[TBL] [Abstract][Full Text] [Related]
32. Radiotherapy after hyperbaric oxygenation improves radioresponse in experimental tumor models.
Kunugita N; Kohshi K; Kinoshita Y; Katoh T; Abe H; Tosaki T; Kawamoto T; Norimura T
Cancer Lett; 2001 Mar; 164(2):149-54. PubMed ID: 11179829
[TBL] [Abstract][Full Text] [Related]
33. Use of 3'-deoxy-3'-[18F]fluorothymidine PET to monitor early responses to radiation therapy in murine SCCVII tumors.
Yang YJ; Ryu JS; Kim SY; Oh SJ; Im KC; Lee H; Lee SW; Cho KJ; Cheon GJ; Moon DH
Eur J Nucl Med Mol Imaging; 2006 Apr; 33(4):412-9. PubMed ID: 16404598
[TBL] [Abstract][Full Text] [Related]
34. Forphenicinol enhances the antitumor effects of cyclophosphamide in a model of squamous cell carcinoma.
Murphy KT; Wardak A; Beckett MA; Lopez CA; Mehta N; Kimchi E; Salloum RM; Jaskowiak NT; Posner MC; Ohno T; Kufe DW; Weichselbaum RR; Mauceri HJ
Cancer Chemother Pharmacol; 2005 Sep; 56(3):317-21. PubMed ID: 15887016
[TBL] [Abstract][Full Text] [Related]
35. The biological effect of pentoxifylline on the survival of human head and neck cancer cells treated with continuous low and high dose-rate irradiation.
Danielsson A; Karlsson E; Delle U; Helou K; Mercke C
J Cancer Res Clin Oncol; 2005 Jul; 131(7):459-67. PubMed ID: 15776273
[TBL] [Abstract][Full Text] [Related]
36. Tumor radiosensitization by antiinflammatory drugs: evidence for a new mechanism involving the oxygen effect.
Crokart N; Radermacher K; Jordan BF; Baudelet C; Cron GO; Grégoire V; Beghein N; Bouzin C; Feron O; Gallez B
Cancer Res; 2005 Sep; 65(17):7911-6. PubMed ID: 16140962
[TBL] [Abstract][Full Text] [Related]
37. The response of hypoxic cells in SCCVII murine tumors to treatment with cisplatin and x rays.
Yan RD; Durand RE
Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):271-4. PubMed ID: 1991687
[TBL] [Abstract][Full Text] [Related]
38. Combination of EGFR/HER2 tyrosine kinase inhibition by BIBW 2992 and BIBW 2669 with irradiation in FaDu human squamous cell carcinoma.
Schütze C; Dörfler A; Eicheler W; Zips D; Hering S; Solca F; Baumann M; Krause M
Strahlenther Onkol; 2007 May; 183(5):256-64. PubMed ID: 17497097
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic gain factors for fractionated radiation treatment of spontaneous murine tumors using fast neutrons, photons plus O2(1) or 3 ATA, or photons plus misonidazole.
Suit HD; Sedlacek R; Silver G; Hsieh CC; Epp ER; Ngo FQ; Roberts WK; Verhey L
Radiat Res; 1988 Dec; 116(3):482-502. PubMed ID: 3205910
[TBL] [Abstract][Full Text] [Related]
40. Reoxygenation and rehypoxiation in the SCCVII mouse tumor.
Kim IH; Brown JM
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):493-7. PubMed ID: 8005805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
